AMERICAN SHARED HOSPITAL SERVICES Long-Term Debt, Maturity, after Year Five
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Long-Term Debt, Maturity, after Year Five of $3.04 million as of 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2025-04-04
- 2024-12-31: Long-Term Debt, Maturity, after Year Five $3.04M.
- 2021-12-31: Long-Term Debt, Maturity, after Year Five $165.00K.
- 2020-12-31: Long-Term Debt, Maturity, after Year Five $466.00K.
- 2019-12-31: Long-Term Debt, Maturity, after Year Five $401.00K.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2024-12-31 | $3.04M 10-K · filed 2025-04-04 |
| 2021-12-31 | $165.00K 10-K · filed 2022-03-30 |
| 2020-12-31 | $466.00K 10-K · filed 2021-04-06 |
| 2019-12-31 | $401.00K 10-K · filed 2020-04-03 |
| 2018-12-31 | $699.00K 10-K · filed 2019-03-29 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-27 |
| 2015-12-31 | $429.00K 10-K · filed 2016-03-30 |
| 2014-12-31 | $867.00K 10-K · filed 2015-04-01 |
| 2013-12-31 | $480.00K 10-K · filed 2014-03-31 |
| 2012-12-31 | $946.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |